Adjuvant aromatase inhibitor therapy and early markers for cardiovascular disease in breast cancer survivors

被引：0
|
作者：
Annemiek van Ommen-Nijhof
Judy N. Jacobse
Lars C. Steggink
Joop D. Lefrandt
Jourik A. Gietema
Flora E. van Leeuwen
Michael Schaapveld
Gabe S. Sonke
机构：
[1] The Netherlands Cancer Institute,Department of Medical Oncology
[2] Leiden University Medical Center,Department of Radiotherapy
[3] Erasmus University Medical Center,Department of Medical Oncology
[4] University Medical Center Groningen,Department of Internal Medicine
[5] University Medical Center Groningen,Department of Medical Oncology
[6] The Netherlands Cancer Institute,Department of Psychosocial Research and Epidemiology
[7] The Netherlands Cancer Institute,Department of Medical Oncology
[8] University of Amsterdam,Department of Medical Oncology
来源：
Breast Cancer Research and Treatment | 2022年 / 196卷
关键词：
Breast cancer; Endocrine therapy; Aromatase inhibitor; Cardiovascular disease;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：591 / 602
页数：11
相关论文
共 50 条
  • [1] Adjuvant aromatase inhibitor therapy and early markers for cardiovascular disease in breast cancer survivors
    van Ommen-Nijhof, Annemiek
    Jacobse, Judy N.
    Steggink, Lars C.
    Lefrandt, Joop D.
    Gietema, Jourik A.
    van Leeuwen, Flora E.
    Schaapveld, Michael
    Sonke, Gabe S.
    BREAST CANCER RESEARCH AND TREATMENT, 2022, 196 (03) : 591 - 602
  • [2] A pilot randomized trial to prevent sexual dysfunction in postmenopausal breast cancer survivors starting adjuvant aromatase inhibitor therapy
    Advani, Pragati
    Brewster, Abenaa M.
    Baum, George P.
    Schover, Leslie R.
    JOURNAL OF CANCER SURVIVORSHIP, 2017, 11 (04) : 477 - 485
  • [3] Aromatase inhibitors as adjuvant therapy for breast cancer
    Maass, N
    Jonat, W
    GYNAKOLOGE, 2003, 36 (02): : 103 - 109
  • [4] Association of Variants in Candidate Genes with Lipid Profiles in Women with Early Breast Cancer on Adjuvant Aromatase Inhibitor Therapy
    Santa-Maria, Cesar A.
    Blackford, Amanda
    Nguyen, Anne T.
    Skaar, Todd C.
    Philips, Santosh
    Oesterreich, Steffi
    Rae, James M.
    Desta, Zeruesenay
    Robarge, Jason
    Henry, Norah Lynn
    Storniolo, Anna M.
    Hayes, Daniel F.
    Blumenthal, Roger S.
    Ouyang, Pamela
    Post, Wendy S.
    Flockhart, David A.
    Stearns, Vered
    CLINICAL CANCER RESEARCH, 2016, 22 (06) : 1395 - 1402
  • [5] The use of aromatase inhibitors in adjuvant therapy for early breast cancer
    Walter Jonat
    Felix Hilpert
    Nicolai Maass
    Cancer Chemotherapy and Pharmacology, 2005, 56 : 32 - 38
  • [6] The use of aromatase inhibitors in adjuvant therapy for early breast cancer
    Jonat, W
    Hilpert, F
    Maass, N
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2005, 56 (Suppl 1) : S32 - S38
  • [7] Duration of Adjuvant Aromatase-Inhibitor Therapy in Postmenopausal Breast Cancer
    Gnant, Michael
    Fitzal, Florian
    Rinnerthaler, Gabriel
    Steger, Guenther G.
    Greil-Ressler, Sigrun
    Balic, Marija
    Heck, Dietmar
    Jakesz, Raimund
    Thaler, Josef
    Egle, Daniel
    Manfreda, Diether
    Bjelic-Radisic, Vesna
    Wieder, Ursula
    Singer, Christian F.
    Melbinger-Zeinitzer, Elisabeth
    Haslbauer, Ferdinand
    Sevelda, Paul
    Trapl, Harald
    Wette, Viktor
    Wimmer, Kerstin
    Gampenrieder, Simon P.
    Bartsch, Rupert
    Kacerovsky-Strobl, Stephanie
    Suppan, Christoph
    Brunner, Christine
    Deutschmann, Christine
    Soelkner, Lidija
    Fesl, Christian
    Greil, Richard
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (05) : 395 - 405
  • [8] Aromatase inhibitor plus ovarian suppression as adjuvant therapy in premenopausal women with breast cancer
    Figg, William D., II
    Cook, Katherine
    Clarke, Robert
    CANCER BIOLOGY & THERAPY, 2014, 15 (12) : 1586 - 1587
  • [9] Adjuvant aromatase inhibitor therapy in early breast cancer: what factors lead patients to discontinue treatment?
    Moscetti, Luca
    Fabbri, Maria Agnese
    Sperduti, Isabella
    Fabrizio, Nelli
    Frittelli, Patrizia
    Massari, Annalisa
    Pompei, Luciano
    D'Auria, Giuliana
    Pofi, Enrico
    Ruggeri, Enzo Maria
    TUMORI, 2015, 101 (05) : 469 - 473
  • [10] What influences aromatase inhibitor continuation intention among breast cancer survivors?
    Seo, Young Kyung
    Park, Jeongok
    Park, Jin-Hee
    Kim, Sue
    KOREAN JOURNAL OF WOMEN HEALTH NURSING, 2021, 27 (01): : 49 - 57
12345